Results 61 to 70 of about 1,132 (102)

[Mechanistic research progress on radiotherapy resistance of cancer stem cells]. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Luo Z, Yu M, Li J, Zhang S, Shen T.
europepmc   +1 more source

[Elevated TMCO1 expression in gastric cancer is associated poor prognosis and promotes malignant phenotypes of tumor cells by inhibiting apoptosis]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Song B, Zhou R, Xu Y, Shi J, Zhang Z, Li J, Geng Z, Song X, Wang L, Wang Y, Zuo L.   +10 more
europepmc   +1 more source

[Construction and application of oral squamous cell carcinoma organoid bank]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Xie S, Wang L, Zhang X, Feng Q, Xia Y, Dai Z, Shan X, Cai Z.   +7 more
europepmc   +1 more source

[Molecular imprinting strategies and advances targeting biomembranes]. [PDF]

Se Pu
Yuan XT, Wang L, Chen LX, Hu LH.
europepmc   +1 more source

[Primary hepatic neuroendocrine neoplasms: a case series analysis of 10 patients and literature review]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Jiang Y, Meng Y, Zhang S, Wang Y, Wang C, Lu C.   +5 more
europepmc   +1 more source

[High YEATS2 expression promotes epithelial-mesenchymal transition in gastric cancer cells by activating the Wnt/β-catenin signaling pathway]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Jiang X, Huang Q, Xu Y, Wang S, Zhang X, Wang L, Wang Y, Zuo L.   +7 more
europepmc   +1 more source

[Research progress on serum chitinase-3-like protein 1 for diagnosing early-stage liver fibrosis non-invasively]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Li XN, Wang B.
europepmc   +1 more source

[CT radiomics<b>-</b>driven lung cancer subtyping based on pretreatment imaging: A single<b>-</b>center retrospective cohort study]. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Han F, Zhang J, Wang X, Wu F, Chen C, Yi X.   +5 more
europepmc   +1 more source

[Clinical Progress and Prospects of Antibody-drug Conjugates in Advanced NSCLC]. [PDF]

Zhongguo Fei Ai Za Zhi
Zhong Y, Wang J, Wu L.
europepmc   +1 more source

[Advances in Antibody-drug Conjugates for Non-small Cell Lung Cancer 
after Resistance to First-line Therapy]. [PDF]

Zhongguo Fei Ai Za Zhi
Li H, Jing Y, Sun J, Xu J, Li Y.
europepmc   +1 more source